Menu Close

Articles on HIV

Displaying 1 - 20 of 314 articles

Black men who have sex with men in Southern states have a low rate of using HIV prevention treatments. yacobchuk/iStock/Getty Images Plus via Getty Images

Use of HIV prevention treatments is very low among Southern Black gay men

This finding suggests public health efforts will have to address the treatment barriers these men face – like poverty or homophobia – to meet the nation’s goal of ending the HIV epidemic by 2030.
Little information is available to college students on stopping the spread of COVID-19 within an intimate relationship. DisobeyArt/iStock via Getty Images Plus

Why COVID-19 must be included in safer sex messaging on college campuses

Schools have not adequately educated students about the increased risks of virus transmission when it comes to being sexually intimate.
The estimated lifetime costs of antiretroviral therapy for someone who acquires HIV at age 35 is $358,380. YakubovAlim/iStock via Getty Images Plus

Combining an HIV vaccine with immunotherapy may reduce the need for daily medication

People with HIV need to take daily medication to keep the virus at bay. A study has found that a new treatment combination could boost immunity and control virus levels even after stopping medication.
Healthcare worker, Boitsholo Mfolo, inside the digital x-ray truck at one of Africa Health Research Institute’s mobile screening camps in rural KwaZulu Natal, South Africa. Samora Chapman/ Africa Health Research Institute

Study shows a huge burden of undiagnosed disease in a rural South African district

South Africa needs a public health response that expands the successes of the country’s HIV testing and treatment programme to provide care for multiple diseases.
Missing targets to end HIV in children represents nothing less than a global failure. Sunil Pradhan/SOPA Images/LightRocket via Getty Images

Ending HIV in children is way off target: where to focus action now

Not achieving the targets for children and adolescents in sub-Saharan Africa means that new infections will continue to increase and HIV related mortality will be a reality for decades to come.
A lab worker extracts DNA from samples for further tests at the AIDS Vaccine Design and Development Laboratory Dec. 1, 2008 in New York City. Chris Hondros/Getty Images

HIV/AIDS vaccine: Why don’t we have one after 37 years, when we have several for COVID-19 after a few months?

Scientists developed vaccines for COVID-19 in a matter of months. Why after 37 years do we still not have one for HIV/AIDS? On HIV Vaccine Awareness Day, it’s an important question to ask.

Top contributors

More